Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?

INTRODUCTION: Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia may result in clinical failure of vancomycin therapy, together with prolonged infection and hospitalization. This clinical problem has resulted in a search for more effective treatment options. The current...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Infect Dis Ther
Egile Nagusiak: Bakthavatchalam, Yamuna Devi, Ralph, Ravikar, Veeraraghavan, Balaji, Babu, Priyanka, Munusamy, Elakkiya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6374240/
https://ncbi.nlm.nih.gov/pubmed/30460607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-018-0224-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak